Particularly, the findings revealed a previously unknown role for SLITRK1 in obesity prevention, expanding our understanding of the molecular mechanisms underlying this complex metabolic disorder and shedding light on potential targets for therapeutic interventions against obesity. Here, SLITRK1 is linked to obesity due to melanocortin 4 receptor deficiency.